NCT06798636View on ClinicalTrials.gov

PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions
Self Harm
Interventions
DRUG

Psilocybin 5 mg with cognitive behavioural therapy intervention

This is an oral 5mg psilocybin dose preceding a mental imagery rescripting procedure

DRUG

Placebo with cognitive behavioural therapy intervention

This is an oral placebo comparator preceding a mental imagery rescripting procedure

All Listed Sponsors
lead

Imperial College London

OTHER